Senior insider sale
CEO at XENON PHARMACEUTICALS INC. — senior position signals high conviction
$7.24M
178.94K shares
PIMSTONE SIMON N. plans to sell 178.94K shares of XENON PHARMACEUTICALS INC. valued at approximately $7.24M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Equity Incentive Grant
See remarks
Equity Incentive Grant
See remarks
Equity Incentive Grant
See remarks
Equity Incentive Grant
See remarks
Equity Incentive Grant
See remarks
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/16/2019 | Equity Incentive Grant See remarks | 95K | — |
3/12/2018 | Equity Incentive Grant See remarks | 27K | — |
3/13/2017 | Equity Incentive Grant See remarks | 140K | — |
3/11/2016 | Equity Incentive Grant See remarks | 50K | — |
12/18/2015 | Equity Incentive Grant See remarks | 30.68K | — |
| Total | 342.68K | ||
Completed
Units to sell
14.08K
Market value
$572.5K
Units to sell
14.44K
Market value
$568.0K
Units to sell
32.60K
Market value
$1.26M
Units to sell
18K
Market value
$694.1K
Units to sell
4.92K
Market value
$184.5K
Units to sell
2.95K
Market value
$110.0K
Units to sell
9.88K
Market value
$379.8K
Units to sell
12.07K
Market value
$460.7K
Planned — Approximate Date
Units to sell
70K
Market value
$3.00M
Units
178.94K
Value
$7.24M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/11/2024 | 14.08K | $572.5K | — | Completed |
7/10/2024 | 14.44K | $568.0K | — | Completed |
7/9/2024 | 32.60K | $1.26M | — | Completed |
6/28/2024 | 18K | $694.1K | — | Completed |
6/24/2024 | 4.92K | $184.5K | — | Completed |
6/20/2024 | 2.95K | $110.0K | — | Completed |
6/12/2024 | 9.88K | $379.8K | — | Completed |
6/5/2024 | 12.07K | $460.7K | — | Completed |
| Planned — Approximate Date | ||||
7/12/2024 | 70K | $3.00M | NASDAQ | Planned |
| Total | 178.94K | $7.24M | ||